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Abstract Rationale: Chronic intermittent administration
of amphetamine and cocaine can precipitate psychotic
episodes in humans and produce persistent behavioral
changes (i.e. increased locomotion, stereotypy) in the rat.
The psychostimulant sensitization model of psychosis
holds that the repeated administration of drugs such as
amphetamine and cocaine induces long-lasting neuroad-
aptations and behavioral outcomes in animals that paral-
lel aspects of the schizophrenic condition. Objectives: In
the present study, we attempted to validate this model
further by examining the effects of short-term withdraw-
al from repeated administration of cocaine and amphet-
amine on performance in two animal behavioral models
of cognitive deficits found in schizophrenia: latent inhi-
bition and prepulse inhibition. Reductions in both of
these behavioral phenomena have been reported in
schizophrenic patients and in acutely amphetamine-treat-
ed rats. Methods: Animals were tested after 4 days of
withdrawal from 5 days of daily systemic 20 mg/kg co-
caine or 1.5 mg/kg amphetamine injections for either la-
tent inhibition of two-way active avoidance acquisition
or prepulse inhibition of an acoustic startle response.
Results: Our results indicate that, rather than reducing
the expression of these behaviors, withdrawal from ei-
ther cocaine or amphetamine enhanced the expression of
latent inhibition of the active avoidance response while
having no effect on prepulse inhibition of acoustic startle.
Conclusions: These data indicate that although the sensi-
tized response to amphetamine and cocaine administra-
tion may model some aspects of schizophrenic psycho-
sis, behaviors exhibited by sensitized animals in the ab-
sence of an acute drug challenge are not consistent with
models of the positive symptoms of schizophrenia.
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Introduction
Both amphetamine and cocaine can induce behavioral
states which resemble the psychotic episodes observed in
acutely schizophrenic patients (Snyder 1973; Post 1975;
Brady et al. 1991). This observation has led to the devel-
opment of the psychostimulant sensitization model of
schizophrenia, in which the enhanced locomotor and ste-
reotypic responses of rodents to repeated psychostimu-
lant administration are studied for their relevance to the
positive symptoms of schizophrenia (i.e. delusions, hal-
lucinations, paranoia) in humans (Robinson and Becker
1986; Pierce and Kalivas 1997). In contrast to the effects
of repeated drug administration, the abrupt termination
of chronic psychostimulant intake by human drug users
can result in symptoms of dysphoria, anhedonia, anxiety
and drug craving (Gawin and Kleber 1986; Gawin 1991;
Lago and Kosten 1994). Such symptoms can also be ef-
fectively modelled in the psychostimulant-withdrawn rat
(Leith and Barrett 1976; Markou and Koob 1991; Harris
and Aston-Jones 1993; Sarnyai et al. 1995; Borowski
and Kokkinidis 1998; Barr et al. 1999; Barr and Phillips
1999; Murphy et al. 2001) and have been postulated to
contribute to the high frequency of relapse among re-
cently-withdrawn addicts.
The presence of altered behavioral states during with-
drawal from psychostimulant administration reflects
functional changes in the response of the nervous system
to stimuli other than the previously administered drug.
Although such changes may be more in line with the
symptoms of anhedonia and increased anxiety that char-
acterize psychostimulant withdrawal than with the posi-
tive symptoms of schizophrenia which repeated drug ad-
ministration is believed to simulate, it would be useful to
examine further the cognitive consequences of psycho-
stimulant withdrawal in the rat as these may be relevant
to the schizophrenic condition. Two animal behavioral
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models believed to reflect cognitive/attentional deficits
typical of schizophrenic patients are latent inhibition (LI)
of classically-conditioned responding and prepulse inhi-
bition (PPI) of the startle response.
LI is the process by which repeated non-reinforced
pre-exposure to a conditioned stimulus (CS, e.g. tone)
retards conditioning to the same stimulus when it is sub-
sequently paired with reinforcement (unconditioned
stimulus (UCS), e.g. shock; Lubow 1973). PPI is the
normal reduction in response amplitude to a startling
stimulus when it is immediately preceded by a less in-
tense, non-startling stimulus and is believed to represent
an operational measure of sensorimotor gating ability
(Graham 1975; Hoffman and Ison 1980; Koch and
Schnitzler 1997). Reductions in both LI and PPI have
been reported in schizophrenic patients (Braff et al.
1978; Baruch et al. 1988; Braff and Geyer 1990; Geyer
et al. 1990; Gray et al. 1992; 1995; but see Swerdlow et
al. 1996). These deficits in PPI and LI may reflect, re-
spectively, the sensorimotor gating impairments and the
inability to ignore irrelevant stimuli which are character-
istic of many schizophrenic patients. In rats, the adminis-
tration of low doses of amphetamine during CS pre-ex-
posure and CS-UCS conditioning attenuates LI, whereas
both typical and atypical antipsychotic drugs antagonize
amphetamine-induced disruptions in LI and potentiate LI
when administered alone (Weiner et al. 1984, 1996; 
Weiner and Feldon 1987; Dunn et al. 1993). PPI is simi-
larly reduced in rats following activation of the DA me-
solimbic system and these reductions are likewise re-
versed by antipsychotic drug pretreatment (Mansbach et
al. 1988; Swerdlow et al. 1992; Taylor et al. 1995). Thus,
there is considerable clinical and experimental evidence
linking dopaminergic (DA) hyperactivity to disruptions
of LI and PPI.
Long-term exposure to psychostimulants reportedly
invokes neurochemical adaptations in the brain that op-
pose the pharmacological effects of the drug and may
persist after termination of drug intake, causing the state
of withdrawal (Koob and Bloom 1988). Consistent with
this idea are studies linking the psychostimulant with-
drawal syndrome to low brain DA activity in both hu-
mans and rats (Parsons et al. 1991; Imperato et al. 1992;
Rossetti et al. 1992; Weiss et al. 1992, 1997; Lago and
Kosten 1994; Kuhar and Pilotte 1996). The presence of
decreased accumbens DA during psychostimulant with-
drawal would likely produce a contrasting pattern of
changes in LI and PPI to the DA-agonistic effects of
acute psychostimulant administration.
Although recent reports have indicated a lack of influ-
ence of prior psychostimulant administration on PPI
(Druhan et al. 1998; Martinez et al. 1999), there are sug-
gestions that PPI can be influenced by a history of psy-
choactive drug intake under specific experimental condi-
tions (Zhang et al. 1998; Martin-Iverson 1999; Byrnes
and Hammer 2000). The effects of withdrawal from
chronic psychostimulant treatment on LI have not been
well investigated; however, we recently found an en-
hancement in the expression of LI of conditioned freez-
ing behavior in animals withdrawn from 5 days of co-
caine administration (Murphy et al. 2001). In the present
study we tested the generalizability of this finding to a
second behavioral paradigm, LI of a two-way active
avoidance response. Animals administered cocaine or
amphetamine once daily for 5 days were tested after 
4 days of withdrawal from drug treatment for the expres-
sion of LI of two-way active avoidance and PPI of the
acoustic startle response. Animals were subsequently
tested with a challenge injection of drug to assess their
degree of locomotor sensitization.
Materials and methods
Subjects
Male Wistar rats [Zur: WIST (HanIbm); 250–350 g] obtained
from our in-house specific-pathogen-free (SPF) breeding facility
were used as subjects in these experiments. Animals were singly
housed in a temperature (21±1°C) and humidity (55±5%) con-
trolled animal facility and maintained on a reversed 12:12 light-
dark cycle (lights off at 7:00 a.m.) with ad libitum access to food
and water. All procedures were carried out during the dark phase
of the light-dark cycle. These procedures were performed in accor-
dance with the regulations of the Swiss Federal Veterinary Office.
Drugs
d-Amphetamine sulfate (Research Biochemicals International, 
Natick, Mass., USA) and cocaine hydrochloride (Firma Anseler
AG, Herisau, Switzerland) were dissolved in a 0.9% NaCl solution
to obtain concentrations of 1.5 mg/ml amphetamine (calculated as
the salt) and 20 mg/ml cocaine, respectively. Vehicle-treated
groups received 0.9% NaCl solution. All solutions were adminis-
tered IP in a volume of 1 ml/kg. The cocaine and amphetamine
dosing schedules used in this study were chosen on the basis of
previous work in our laboratory demonstrating robust locomotor
sensitization to subsequent drug challenge following these pre-
treatments.
Apparatus
Two-way active avoidance
Four identical two-way shuttle boxes (Coulbourn Instruments,
model E10-16TC), each set in a ventilated, sound-insulated isola-
tion cubicle (Coulbourn Instruments, model E10-20) were used in
tests of two-way active avoidance behavior. Each box was 35 cm
long, 17 cm deep, and measured 21.5 cm in height from the raised
grid floor. A 4-cm high aluminum hurdle served as a barrier that
separated the box into two identical compartments. The hurdle
was low enough to allow the subject to shuttle freely between the
two compartments, and was thin enough to ensure that the subjects
could not stand on it to avoid foot shocks. The grid floor (Model
E10-16RF) consisted of 24 stainless steel rods with a diameter of
0.48 cm, spaced 1.5 cm apart center to center, through which
scrambled foot shocks were delivered by a constant current shock
generator (Coulbourn Instruments, Model E13-14) and scanner
(Model E13-13) set at 0.5 mA. The conditioned stimulus (CS) was
an 85-dB [A] tone produced by a 2.9 kHz tone module (Coulbourn
Instruments, Model E12-02) placed behind the shuttle box on the
floor of the isolation cubicle. Background noise was provided by a
ventilation fan affixed to each isolation cubicle.
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Prepulse inhibition of acoustic startle
Prepulse inhibition (PPI) testing was conducted in four startle
chambers (SR-LAB, San Diego Instruments, San Diego, Calif.,
USA), each consisted of a transparent Plexiglas tube (diameter
8.2 cm, length 20 cm) mounted on a Plexiglas frame within a
ventilated enclosure. A speaker mounted 24 cm above the tube
provided the acoustic noise bursts. Startle pulses consisted of
120 dB[A] broad band bursts of 30 ms duration. Prepulses,
20 ms of broad band burst, had intensities of either 72, 76, 80 or
84 dB[A]. The time interval between the prepulse offset and the
pulse onset was always 80 ms. Background noise of 70 dB[A]
was maintained throughout the session. A piezoelectric acceler-
ometer mounted below the frame detected and transduced mo-
tion within the tube. Startle amplitudes were defined as the aver-
age of 100, 1-ms stabilimeter readings collected from stimulus
onset.
Locomotor activity
Locomotor activity was assessed in circular polycarbonate test
chambers (30 cm diameter, 35 cm high walls) with sawdust bed-
ding covering the floor. An infrared sensor unit (Coulbourn Instru-
ments, Model E24-61) was positioned at a 15° angle, 10 cm above
the top of the chamber. Movement units detected by the sensor
were transmitted through an infrared motion interface (Coulbourn
Instruments, Model E91-12-421) to an infrared motion activity
monitor controller/analyser (Habitest Universal Link, Coulbourn
Instruments).
Experiment 1: effects of psychostimulant withdrawal 
on two-way active avoidance acquisition and latent inhibition
On each of 3 days prior to conducting any experimental proce-
dures, each rat was handled for an average of 3 min. The effects of
cocaine (COC) and amphetamine (AMPH) withdrawal on latent
inhibition of active avoidance acquisition were studied in compar-
ison to independent groups of saline vehicle (VEH)-treated ani-
mals. All animals were injected IP once every day for 5 consecu-
tive days with 20 mg/kg COC, 1.5 mg/kg AMPH or VEH. Injec-
tions were administered between 0900 and 1000 hours.
Conditioned active avoidance testing was carried out over 3 days,
consisting of 2 days of pre-exposure to the test apparatus and/or
tone CS and 1 day of two-way avoidance acquisition testing. The
first pre-exposure session was conducted 2 days after the last vehi-
cle or psychostimulant injection; consequently, active avoidance
testing was performed after a 4-day withdrawal period. On each of
the 2 pre-exposure days (sessions beginning at 1000 hours), ani-
mals were placed in the boxes for 50 min, with the house light on
continuously. Half of the animals were tone-pre-exposed (PE);
that is, they experienced 50 presentations of a 10-s-tone condi-
tioned stimulus (CS) during each of the two pre-exposure sessions
(variable inter-trial interval (ITI); mean ITI=50 s, range=10–90 s).
The remaining half of the animals comprised the non-pre-exposed
(NPE) groups, which did not hear the tone CS during either pre-
exposure session. The number of spontaneous crosses between the
two sides of the shuttle box was recorded during both pre-expo-
sure sessions to provide a measure of basal activity level. On the
avoidance test day each subject was placed in the appropriate
shuttle box and 100 avoidance trials were administered, again with
a variable ITI (mean=50 s, range=10–90 s). Each avoidance trial
began with the onset of the 10-s tone CS. If a subject failed to
shuttle to the other side within 10 s after CS onset (i.e., an avoid-
ance response), a foot shock of 0.5 mA was delivered, the CS re-
maining on with the shock. The maximal duration of the shock
was 2 s. A shuttle during this period (i.e., an escape) terminated
the shock as well as the CS. If a subject failed to shuttle during the
12-s period, it was recorded as a non-escaped trial.
One day following active avoidance testing, all of the AMPH-
withdrawn animals and half of the COC-withdrawn animals were
assessed for their locomotor response to a challenge injection of
either AMPH or COC, respectively. Each rat was first placed in
the activity chamber for a 30-min habituation session. Subsequent-
ly, animals were injected with 0.9% saline vehicle, and placed into
the chamber for an additional 30-min session. Finally, animals re-
ceived a psychostimulant injection, and their locomotor response
to drug was monitored for 60 min. Animals previously tested for
the effects of amphetamine withdrawal on active avoidance were
administered an injection of AMPH (1.5 mg/kg, IP) and animals
previously tested for the effects of cocaine withdrawal received an
injection of COC (20 mg/kg, IP).
Experiment 2: effects of psychostimulant withdrawal on prepulse
inhibition of acoustic startle
Solutions of AMPH, COC and VEH were administered according
to the same injection schedule and in the same dosages as de-
scribed for experiment 1. Animals were tested for prepulse inhibi-
tion of acoustic startle 4 days after their last injection, the same
withdrawal interval at which latent inhibition of active avoidance
was measured in experiment 1. The startle session began with a 
5-min acclimatization period during which only 70 dB [A] back-
ground noise was presented. This background noise continued
throughout the remainder of the test session. After the acclimatiza-
tion period, four startle pulses of 120 dB [A], each of 30-ms dura-
tion, were presented to permit an initial test of startle responding
prior to the onset of prepulse testing. This “warm-up” period was
followed by six blocks of 11 test trials each. Each block of trials
consisted of four different trial types presented pseudo-randomly
throughout the whole session, i.e. pulse alone (two trials), prepulse
alone (one trial for each of the four prepulse intensities), prepulse
followed by a pulse (one trial for each of the four prepulse intensi-
ties) or no stimulus (one trial).
Statistical analysis
All statistical analyses were performed using the StatView statis-
tical software package. ANOVAs with between-subjects factors
of Drug treatment (COC versus VEH or AMPH versus VEH) and
Pre-exposure condition (PE versus NPE) and a repeated measure-
ments factor of Blocks of ten trials were used to analyze group
differences in percentage avoidance responses. One-way factorial
ANOVAs were used to analyse the effects of drug treatment on
numbers of spontaneous shuttles during the pre-exposure sessions
and on numbers of inter-trial interval shuttles and non-escaped
trials during avoidance testing. In the prepulse inhibition test,
startle amplitude to the pulse-alone trials was analyzed using AN-
OVAs with a between-subjects factor of Drug (COC versus VEH
or AMPH versus VEH) and a within-subjects factor of either the
first four or the last 12 pulse-alone Trials. The percentage inhibi-
tion of startle induced by each prepulse intensity [% prepulse in-
hibition (PPI)] was calculated as: 100–(100×startle amplitude on
prepulse trial)/(mean startle amplitude on pulse alone trials). The
mean percentage PPI was analyzed using a 2×4 ANOVA with a
between-subjects factor of Drug (COC versus VEH or AMPH
versus VEH) and a within-subjects factor of Prepulse intensity
(72, 76, 80 and 84 dB [A]). Locomotor activity data were ana-
lyzed separately for each testing session using two-way ANOVAs
with a between-subjects factor of Drug (COC versus VEH or
AMPH versus VEH) and a within-subjects factor of 10-min
Blocks.
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Results
Experiment 1: effects of psychostimulant 
withdrawal on two-way active avoidance acquisition 
and latent inhibition
Amphetamine withdrawal
A comparison of the number of shuttles made during the
two pre-exposure sessions (Table 1) revealed a signifi-
cant effect of Session [F(1,28)=27.1, P<0.0001], reflect-
ing greater activity during the first pre-exposure session
compared to the second, as well as a significant effect of
Pre-exposure condition [F(1,28)=5.1, P<0.05] such that
pre-exposed (PE) animals shuttled less frequently during
these sessions than non-pre-exposed animals (NPE).
Amphetamine-treated (AMPH) and vehicle-treated
(VEH) groups made similar numbers of shuttles during
both sessions, regardless of Pre-exposure condition.
An analysis of percentage avoided trials during test
(Fig. 1A, C) using a 2×2×10 ANOVA (Drug Treat-
ment×Pre-exposure condition×Blocks of ten trials) re-
vealed highly significant main effects of Pre-exposure
condition [F(1,28)=12.1, P<0.002] and Blocks [F(9,252)=
28.1, P<0.001], a significant interaction of Pre-exposure
condition×Blocks [F(9,252)=2.0, P<0.05] and a signifi-
cant interaction of Pre-exposure condition×Drug treat-
ment×Blocks [F(9,252)=2.1, P<0.05]. These effects re-
flect the fact that latent inhibition, i.e. reduced avoidance
performance in PE compared to NPE rats, was evident in
AMPH- but not VEH-treated animals, a group difference
which was most apparent toward the end of the avoid-
ance test session, when the proportion of avoided trials
was highest in all groups. This result was further sup-
ported by two separate 2×10 ANOVAs comparing PE
and NPE groups within each drug treatment condition.
An analysis confined to the AMPH groups yielded a
highly significant main effect of Pre-exposure condition
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Table 1 Numbers of shuttles made during 2 days of avoidance ap-
paratus and/or tone CS pre-exposure. Tone-pre-exposed (PE) and
non-pre-exposed (NPE) animals were placed in the shuttle boxes
on day 2 (PE day 1) and day 3 (PE day 2) of withdrawal from 5
days of amphetamine (AMPH), cocaine (COC) or saline vehicle
(VEH) injections. Amphetamine experiment: n=8 per group. 
Cocaine experiment: n=12 per group. Values are means±SEM
Avoidance experiment Drug condition Pre-exposure condition PE day 1 PE day 2
Amphetamine VEH NPE 41±7 32±7
VEH PE 33±9 23±5
AMPH NPE 46±6 34±3
AMPH PE 32±5 16±3
Cocaine VEH NPE 41±7 29±5
VEH PE 28±4 22±3
COC NPE 40±5 30±4
COC PE 23±2 16±2
Fig. 1 Percentage avoided tri-
als during a 100-trial test of
two-way active avoidance in
animals that had been previous-
ly treated with five daily injec-
tions of A, B saline vehicle,
C amphetamine or D cocaine.
All animals were tested 4 days
after their last drug or vehicle
injection. On each of 2 days
prior to avoidance testing, ani-
mals were placed in the shuttle
box for a 45-min habituation
session during which time ani-
mals in the pre-exposed (PE)
groups were presented with 30,
10-s tones and animals in the
non-pre-exposed (NPE) groups
experienced no other stimuli.
Amphetamine experiment: n=8
per group. Cocaine experiment:
n=12 per group. Values are
means±SEM
[F(1,14)=24.7, P<0.001] and a significant interaction of
Pre-exposure condition×Blocks [F(9,126)=3.2, P<0.002].
A similar analysis for the VEH groups revealed neither a
significant effect of Pre-exposure condition (P=0.32) nor
a Pre-exposure condition×Blocks interaction (P=0.53).
Numbers of non-escaped trials and inter-trial interval
shuttles made during the avoidance test session did not
differ as a function of either Drug treatment or Pre-expo-
sure condition (data not shown).
Cocaine withdrawal
A comparison of the number of crossings made during
the two shuttle box pre-exposure sessions (Table 1)
again revealed a significant effect of Session [F(1,44)=
34.1, P<0.0001], reflecting a generally higher level of
activity on the first pre-exposure day compared to the
second day. There was also a significant main effect of
CS Pre-exposure condition [F(1,44)=9.9, P<0.01] due
to the decreased number of shuttles made by PE com-
pared to NPE animals. Shuttles made during the pre-ex-
posure sessions did not differ between cocaine-treated
(COC) and VEH animals, regardless of Pre-exposure
condition.
An overall 2×2×10 ANOVA (Drug treatment×Pre-ex-
posure condition×Blocks of ten trials) of percentage
avoidance responses during test (Fig. 1B, D) yielded a
highly significant main effect of Blocks [F(9,396)=37.6,
P<0.001] reflecting increasing numbers of successfully
avoided trials throughout the test session. A significant
main effect of Pre-exposure condition [F(1,44)=6.7,
P<0.015] was noted as well. Although there was no sig-
nificant Drug×Pre-exposure interaction in this analysis,
the main effect of CS pre-exposure was almost entirely
due to PE versus NPE differences in the COC-treated
groups. This observation was confirmed by separate
2×10 ANOVAs (Pre-exposure×Blocks of ten trials) 
within each of the drug treatment conditions. Although 
a significant main effect of Pre-exposure condition
[F(1,22)=6.3, P<0.05] was determined for the COC
groups, indicating significant latent inhibition, no effects
of CS pre-exposure were found for the VEH groups (no
main effect of Pre-exposure condition: P=0.31; no Pre-
exposure condition×Blocks interaction: P=0.93). Num-
bers of non-escaped trials and inter-trial interval shuttles
made during the avoidance test session did not differ as a
function of either Drug treatment or Pre-exposure condi-
tion (data not shown).
Experiment 2: effects of psychostimulant withdrawal 
on prepulse inhibition of acoustic startle
Amphetamine withdrawal
Startle response amplitudes (Fig. 2A) were analyzed
with two-way repeated-measures ANOVAs (Drug treat-
ment×Trials). Startle response amplitudes habituated
similarly for the two drug treatment conditions during
the first four “warm-up” presentations of the startle pulse
[2×4 ANOVA, main effect of Trial: F(3,90)=3.4,
P<0.05]. Although visual inspection of the data suggests
that the AMPH group exhibited somewhat dampened
startle responses during the latter part of the test session,
a 2×12 ANOVA of the last 12 startle pulse presentations
did not detect a significant effect of Drug pretreatment
[non-significant effect of Drug: F(1,30)=1.77, P=0.19].
A 2×4 ANOVA (Drug treatment×Prepulse intensity) re-
vealed a significant main effect of Prepulse intensity on
inhibition of the startle response [F(1,90)=44.9,
P<0.0001] such that prepulses of greater intensity pro-
duced stronger response inhibition (Fig. 3A). However,
percentage PPI was not influenced by prior history of
AMPH treatment, as no significant differences were ob-
served between AMPH and VEH groups. 
Cocaine withdrawal
An analysis of startle response amplitudes (Fig. 2B) did
not reveal significant differences between the responses
of the COC and VEH groups to the acoustic startle stim-
ulus. Startle response amplitudes during the first four
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Fig. 2 Startle responses during 16 pulse-alone trials in the pre-
pulse inhibition test in animals previously treated with five daily
injections of A amphetamine (AMPH), B cocaine (COC) or A, B
saline vehicle (VEH). All animals were tested 4 days after their
last drug or vehicle injection. n=8 per group. Values are means
±SEM
“warm-up” pulse presentations showed the expected re-
sponse habituation [2×4 ANOVA, main effect of Trials:
F(3,90)=2.9, P<0.05] and did not differ between drug
treatment groups. However, similarly to the AMPH with-
drawal experiment, COC animals demonstrated a non-
significant reduction in startle response amplitudes to the
pulse-alone trials to the last 12 startle pulse presentations
[non-significant effect of Drug: F(1,30)=2.11, P=0.16].
A two-way ANOVA (Drug treatment×Prepulse intensity)
performed on percentage PPI did not detect any differ-
ences between the COC and VEH groups (Fig. 3B); as
expected, however, there was again a significant effect of
the factor of prepulse intensities [F(3,90)=54.8,
P<0.0001] reflecting a gradual increase in PPI as a func-
tion of the intensity of the prepulse stimulus.
Locomotor sensitization to psychostimulants
Animals used in experiment 1 were tested on day 5 of
the drug withdrawal period for their locomotor response
to a challenge injection of either AMPH or COC (AMPH
withdrawal experiment: n=16 per drug condition, using
pooled PE and NPE groups; COC withdrawal experi-
ment: only half of the animals were tested, i.e. n=8 per
drug condition, using pooled PE and NPE groups; see
Fig. 4). Analyses using 2×3 ANOVAs (Drug treat-
ment×10-min Blocks) revealed no significant effects of
either prior COC or AMPH treatment on locomotor ac-
tivity measured during either the 30-min habituation pe-
riod or during the 30-min period which followed an in-
jection of saline vehicle, although highly significant ef-
fects of Blocks were detected for both sessions which re-
flect the normal reductions in locomotion that follow
placement into a novel environment [AMPH withdrawal
experiment: habituation period – F(2,60)=60.35, P<0.0001;
saline injection period – F(2,60)=17.89, P<0.0001; COC
withdrawal experiment: habituation period – F(2,28)=
17.65, P<0.0001; saline injection period – F(2,28)=
41.27, P<0.0001]. Both the COC- and AMPH-treated
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Fig. 3 Percentage prepulse inhibition (PPI) of the acoustic startle
response in animals previously treated with A amphetamine
(AMPH), B cocaine (COC) or A, B saline vehicle (VEH), mea-
sured using a range of prepulse intensities (72, 76, 80 or 84 dB
[A]) 4 days after their last injection. n=8 per group. Values are
means±SEM
Fig. 4 Locomotor activity measured during an initial 30-min peri-
od in a novel open field environment, a 30-min period following
an injection of saline vehicle, and a 1-h period following a chal-
lenge injection with either A amphetamine (1.5 mg/kg) or B co-
caine hydrochloride (20 mg/kg, IP) in animals previously treated
over 5 days with amphetamine (AMPH), cocaine (COC) or saline
vehicle (VEH). All animals were tested 5 days after their last drug
or vehicle injection. Amphetamine experiment: n=8 per group.
Cocaine experiment: n=4 per group. *P<0.05 compared to VEH
group. Values are means±SEM
groups demonstrated a modest degree of behavioral sen-
sitization to a challenge injection of drug. A 2×6 AN-
OVA (Drug treatment×10-min Blocks) revealed signifi-
cant main effects of Blocks for both AMPH- and COC-
pretreated rats [AMPH withdrawal experiment:
F(5,150)=10.23, P<0.0001; COC withdrawal experi-
ment: F(5,70)=4.83, P<0.001]. AMPH-withdrawn ani-
mals demonstrated increased locomotor activity com-
pared to the VEH group, particularly during the first
20 min following administration of a challenge injection
of AMPH, an effect which approached statistical sig-
nificance [Drug×Blocks interaction: F(5,150)=2.04,
P=0.076]. Similarly, a significant Drug×Blocks interac-
tion [F(5,70)=2.54, P<0.05] for the COC-challenged
groups reflected the increased locomotor response of
COC-withdrawn animals to subsequent COC administra-
tion compared to the response of animals previously in-
jected with VEH. Half of the animals from experiment 2
were also tested for locomotor sensitization to a chal-
lenge drug injection one day after PPI testing (data not
shown). Activity testing of these animals was carried out
in an open field in combination with the Noldus Ethovi-
sion system (Wageningen, Netherlands) rather than the
infrared-detection locomotor activity monitors used for
animals in Experiment 1; consequently, sensitization da-
ta from experiments 1 and 2 are not directly comparable.
Nevertheless, PPI-tested rats withdrawn from AMPH
showed non-significantly increased locomotor respond-
ing to a drug challenge [main effect of Drug:
F(1,14)=2.66, P=0.12; n=8 per group, data not shown],
and PPI-tested rats withdrawn from COC showed in-
creased activity which was greatest during the first
10 min after drug injection [Drug×Blocks interaction:
F(5,70)=3.6, P<0.01; n=8 per group, data not shown].
Discussion
The results of the present study indicate that animals re-
cently withdrawn from repeated daily COC or AMPH
administration exhibit enhanced latent inhibition (LI) of
two-way active avoidance acquisition. These results are
consistent with those of an earlier investigation on the
effects of chronic AMPH on LI in a conditioned emo-
tional response paradigm (Weiner et al. 1984), in which
LI was non-significantly increased in animals after 
1–2 days of withdrawal from 14 days of amphetamine
treatment. A similar enhancement of LI of conditioned
freezing behavior has also been observed following the
chronic cocaine regimen used in this study (Murphy et
al. 2001). In contrast to these effects on LI, PPI was un-
affected by either prior AMPH or COC treatment.
The increased LI observed following AMPH and
COC withdrawal reflects both reduced avoidance in the
PE groups and improved avoidance in the NPE groups.
Moreover, this effect was recorded on a background of
no LI in the VEH-treated animals. The absence of LI in
the VEH control groups was somewhat surprising, given
the high number of CS pre-exposures that preceded con-
ditioned avoidance testing. Recent experiments in our
laboratory have in fact replicated these results using few-
er CS pre-exposures, again finding no LI in controls and
enhanced LI in AMPH-withdrawn animals (Russig, 
Murphy and Feldon, unpublished findings). The expres-
sion of LI is said to be critically dependent on a number
of different conditioning parameters, as well as general
factors such as environmental stress (Hellman et al.
1983; Hall 1991; Killcross and Balleine 1996). Thus, al-
though it is not clear why the parameters for eliciting LI
vs. no LI may vary somewhat between experiments, the
effects of psychostimulant withdrawal in enhancing LI
under conditions in which LI is absent in the VEH
groups appear to be highly replicable.
Short-term psychostimulant withdrawal is claimed to
induce dysphoric behaviors in rats (Leith and Barrett
1976; Markou and Koob 1991; Barr and Phillips 1999;
Barr et al. 1999). Given that the learned helplessness the-
ory of depression would predict deficits in active avoid-
ance and/or shock escape (McKinney 1984), it is some-
what surprising that NPE-COC and NPE-AMPH sub-
jects in fact tended to avoid footshocks more successful-
ly than NPE-saline animals and experienced similar
numbers of non-escaped trials. However, both AMPH
and COC were administered at relatively low doses and
over a brief period in this study. Demonstrations of de-
pressed reward sensitivity during psychostimulant with-
drawal are typically observed after the administration of
higher doses over a more extended period of time and
are also somewhat transient, such that these effects, if
they did exist, might be diminished even after only 
4 days of withdrawal. In contrast, rats which have been
withdrawn from low-dose drug regimens similar to those
used in this study have been shown to exhibit enhanced
conditioned approach behavior and conditioned inhibi-
tion (Harmer and Phillips 1999) as well as behavioral
signs of anxiety and arousal in the face of environmental
stressors (Harris and Aston-Jones 1993; Sarnyai et al.
1995; Borowski and Kokkinidis 1998; Fiorino and Phil-
lips 1999). The presence of increased anxiety in stimu-
lant-sensitized NPE subjects during withdrawal might
contribute to the somewhat improved avoidance behav-
ior demonstrated by these groups. That is, an increased
state of arousal in these groups could either heighten
their negative experience of the shock or lead to en-
hanced attention to their environment, both effects which
might be expected to increase conditioned avoidance
learning. However, assuming that such a state exists for
the NPE rats, it follows that the AMPH-PE and COC-PE
rats would be similarly influenced; instead, their avoid-
ance performance was non-significantly decreased with
respect to that of VEH controls.
The reduced avoidance acquisition of the drug-PE
groups may reflect a kind of cognitive inflexibility, or an
inability to switch from one learned contingency (tone
CS – nothing) to another (tone CS – shock). Interesting-
ly, Kokkinidis (1983) reported that while mice recently
withdrawn from AMPH do not show an active avoidance
acquisition deficit, they do exhibit reduced extinction of
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the avoidance response to a CS no longer paired with
footshock, perhaps representing a similar type of cogni-
tive perseveration. Observations of enhanced LI in pa-
tients with obsessive-compulsive disorder (OCD; Swerd-
low et al. 1999) are also consistent with this interpreta-
tion. Thus, the co-occurrence of increased anxiety and
increased perseverative behavior in the stimulant-with-
drawn groups might explain the bi-directional effects of
withdrawal on avoidance in NPE and PE rats.
Recent in vivo microdialysis investigations have con-
firmed the importance of nucleus accumbens DA in the
expression of LI (Young et al. 1993; Murphy et al.
2001). Some investigators have suggested that excessive
DA activity in the nucleus accumbens results in rapid
switching from one stimulus-response pattern to another,
and that such a mechanism is responsible for the disrup-
tion of LI in animals treated with acute amphetamine
(Van den Bos and Cools 1989; Weiner and Feldon 1997).
Therefore, enhanced LI might conversely reflect reduced
switching and reduced nucleus accumbens DA. The in-
creased LI found in the present study during COC and
AMPH withdrawal resembles the previously reported
potentiation of LI which occurs when DA-antagonist an-
tipsychotic drugs are administered prior to pre-exposure
and conditioning sessions (Weiner and Feldon 1987;
Dunn et al. 1993; Weiner et al. 1996). There is evidence
that the effects of antipsychotic drugs on LI are mediated
in the nucleus accumbens (Gray et al. 1997); further-
more, reports of reduced DA function in the nucleus acc-
umbens during COC and AMPH withdrawal (Parsons et
al. 1991; Rossetti et al. 1992; Weiss et al. 1992, 1997;
Kuhar and Pilotte 1996) are consistent with the idea that
enhanced LI reflects DA antagonism in mesolimbic tar-
gets during pre-exposure and/or avoidance testing. Nev-
ertheless, reductions in nucleus accumbens DA during
psychostimulant withdrawal are not reported by all labo-
ratories and may be dependent on schedules of drug ad-
ministration or procedural details (Crippens et al. 1993;
Crippens and Robinson 1994); in particular, it is very
possible that the schedule of low-dose AMPH employed
in this study would not have been sufficient to reduce
accumbens DA during withdrawal. Finally, in an earlier
study in which COC was administered subsequent to CS
pre-exposure and CS-UCS conditioning, we also ob-
served enhanced LI of conditioned freezing behavior
during COC withdrawal (Murphy et al. 2001). This earli-
er result suggests that neuroleptic-like effects need not
be experienced during pre-exposure and conditioning to
elicit enhanced LI at test. Therefore, the effects of psy-
chostimulant withdrawal on LI may affect processes of
retrieval rather than acquisition (Kraemer and Spear
1992; Killcross et al. 1998), such that the neuroleptic-
like potentiation of LI in this study may be merely coin-
cidental.
In contrast to the effects of short-term withdrawal from
psychostimulants on LI, drug and VEH groups exhibited
similar levels of PPI of the acoustic startle response as
well as similar degrees of startle during the pulse-alone
trials. The PPI result is consistent with previous reports
which found no lasting effects of prior repeated AMPH,
COC or apomorphine exposure on PPI when animals were
subsequently tested in either a drug-free state or following
a challenge injection of drug (Mansbach et al. 1988; 
Druhan et al. 1998; Martin-Iverson 1999; Martinez et al.
1999); in fact, one study found that chronic COC treat-
ment eliminated rather than augmented the normal defi-
cit produced by acute COC pretreatment (Byrnes and
Hammer 2000). Although LI and PPI are believed to re-
flect similar aspects of cognitive processing, disparities
in the regulation of these phenomena have previously
been reported (Wilkinson et al. 1994; Feldon et al.
2000). The brain nuclei believed to mediate LI and PPI
are also not identical; for example, whereas the prefron-
tal cortex has consistently been implicated in the media-
tion of PPI, prefrontal cortical manipulations do not in-
fluence LI (Ellenbroek et al. 1996; Lacroix et al. 1998;
Broersen et al. 1999). An additional consideration stems
from the potential contribution of the discrepant 
VEH-treated groups’ baselines (no LI versus presence of
PPI) to the relative ability of stimulant withdrawal to
elicit enhancements in these two paradigms. However,
given the low to moderate PPI exhibited by the VEH
groups in this study, we feel that either an enhancement
or disruption in PPI would have been observable under
the conditions used here; therefore, the differential 
VEH-group baselines would not have contributed signif-
icantly to the differential effects of stimulant withdrawal
on LI versus PPI. Nevertheless, there is evidence that
PPI is generally somewhat more resistant to enhance-
ment (Depoortere et al. 1997a, 1997b) than LI, a concern
which may contribute to the lack of effect of psycho-
stimulant withdrawal on PPI observed in the present
study.
Although we did see evidence of locomotor sensitiza-
tion to a challenge injection of COC or AMPH adminis-
tered on day 5 of withdrawal, the activity levels of stim-
ulant-sensitized animals were not markedly greater than
those of saline-treated controls. Behavioral sensitization
to psychostimulants is at least partially context-depen-
dent (Post et al. 1987; Badiani et al. 1995); therefore, the
fact that locomotor activity in response to a drug chal-
lenge was only slightly greater in the AMPH and COC
groups compared to the VEH groups in this study may
be because animals were placed in their home cages after
each injection, but tested for sensitized locomotor re-
sponding in a novel environment.
In conclusion, short-term withdrawal from repeated
administration of low-dose AMPH and COC did not dis-
rupt either LI or PPI; instead, LI was enhanced and PPI
was unaffected by the treatment regimens used in this
study. Thus, withdrawal from psychostimulants does not
produce cognitive deficits consistent with modelling of
the positive symptoms of schizophrenia, despite the rela-
tionship that is believed to exist between this class of
symptoms and sensitized behavioral responding to a
drug challenge. It remains possible that a more intensive
psychostimulant pretreatment than the one used in this
study would induce a different pattern of cognitive ef-
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fects than the ones we observed; thus, further research is
warranted to examine the effects of higher dose sched-
ules of AMPH and COC administration on these behav-
iors. The available literature suggests that the effects of
psychostimulant withdrawal are consistent with symp-
toms of anhedonia and anxiety, or even negative schizo-
phrenic symptoms (i.e. blunted affect, apathy and cogni-
tive disorganization; Andreasen et al., 1995), rather than
the positive symptoms of the disease. Therefore, the en-
hanced LI that we report here may be a sign of cognitive
phenomena more closely related to these psychological
conditions. The findings of the present study suggest that
examination of the consequences of short-term stimulant
withdrawal in the rat may contribute to our understand-
ing of neural mechanisms underlying specific deficits in
cognitive processing and altered emotional states.
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